ACTU
Actuate Therapeutics
ACTU
ACTU
25 hedge funds and large institutions have $70.4M invested in Actuate Therapeutics in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
13% less capital invested
Capital invested by funds: $80.5M → $70.4M (-$10.1M)
Holders
25
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$590K | |
| 2 | +$365K | |
| 3 | +$322K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$124K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$109K |
Top Sellers
| 1 | -$84.2K | |
| 2 | -$83.3K | |
| 3 | -$995 | |
| 4 |
JPMorgan Chase & Co
New York
|
-$24 |
